Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Linde PLC (LIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Linde PLC — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.97 (market cap $31.07B), while Linde PLC trades at $495.3 (market cap $226.85B). The key difference: Linde PLC is far larger — about 7.3× GE HealthCare Technologies Inc. Common Stock's market cap, and Linde PLC pays the higher dividend (1.3%). Which is the better fit depends on your goals.
| GEHC | LIN | |
|---|---|---|
Market Cap | $31.07B | $226.85B |
Volume | 3,443,020 | 1,386,042 |
Sector | Health | Basic Materials |
52-Week High | $88.16 | $546.64 |
52-Week Low | $59.48 | $389.38 |
Enterprise Value | $39.53B | $249.97B |
Dividend Yield | 0.23% | 1.3% |
Typical Hold Time | — | 89 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Linde (LIN) trades at $492.11, up 0.98% today, near its 52-week high. The stock shows a bullish technical trend with strong fundamentals, including a 20.43% net income margin and consistent earnings beats. Recent news highlights its role in AI chip supply chains, while analyst consensus remains strongly positive with a $558.91 price target.
Outlook is favorable given robust profitability and growth in electronics end-markets, but risks include elevated valuation multiples and rising debt levels. The stock offers upside potential aligned with Wall Street optimism, though investors should weigh margin pressures and capital expenditure trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Linde PLC
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $31 billion in revenue and $5 billion in GAAP operating profit in 2021.
Read more on LIN →
